Suppr超能文献

癌症患者临终时的手术治疗强度:一项系统评价。

Surgical Treatment Intensity at the End of Life in Patients With Cancer: A Systematic Review.

作者信息

Lawday Samuel, Zucker Benjamin E, Gardner Shona, Robb James, Leandro Lorna, Hollingworth William, Blazeby Jane, McNair Angus G K, Chamberlain Charlotte

机构信息

From the NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK.

Department of General Surgery, North Bristol NHS Trust, Bristol, UK.

出版信息

Ann Surg Open. 2024 Nov 12;5(4):e514. doi: 10.1097/AS9.0000000000000514. eCollection 2024 Dec.

Abstract

OBJECTIVE

To synthesize evidence of surgical treatment intensity, defined as a measure of the quantity of invasive procedures, received by patients in patients with cancer within a defined time period around the 'end of life' (EoL).

BACKGROUND

Concern regarding overly 'aggressive' care or high health care utilization at the EoL, particularly in cancer, is growing. The contribution surgery makes to the quality and cost of EoL care in cancer has not yet been quantified.

METHODS

This PROSPERO registered systematic review used PRIMSA guidelines to search electronic databases for observational studies detailing surgical intensity at the EoL in adult cancer patients. Intensity was compared by disease, individual characteristics, geographical region, and palliative care involvement. A risk of bias tool assessed quality and a narrative synthesis of findings was completed.

RESULTS

In total, 39 papers were identified in this search. Up to 79% of patients underwent invasive procedures in the last month of life. Heterogeneity in patient groups, inclusion criteria, and EoL time periods lead to huge variation in results, with treatment intention often not identified. Patient, geographical, and pathological factors, alongside involvement of palliative/hospice care, were all identified as contributors to treatment intensity variation.

CONCLUSIONS

A significant proportion of patients with cancer undergo invasive and costly invasive procedures at the EoL. There is significant reporting heterogeneity, with variation in patient inclusion criteria and EoL timeframes, demonstrating uncertainty within the literature. Identification of the context where surgical treatment intensity at the EoL is potentially inappropriate is not currently possible.

摘要

目的

综合关于手术治疗强度的证据,手术治疗强度定义为在“生命末期”(EoL)前后特定时间段内癌症患者接受的侵入性手术数量的一种度量。

背景

对于生命末期过度“激进”的治疗或高医疗资源利用的担忧日益增加,尤其是在癌症领域。手术对癌症患者生命末期护理质量和成本的贡献尚未得到量化。

方法

这项在PROSPERO注册的系统评价使用PRISMA指南检索电子数据库,以查找详细描述成年癌症患者生命末期手术强度的观察性研究。根据疾病、个体特征、地理区域和姑息治疗参与情况对强度进行比较。使用偏倚风险工具评估质量,并完成研究结果的叙述性综合分析。

结果

本次检索共识别出39篇论文。高达79%的患者在生命的最后一个月接受了侵入性手术。患者群体、纳入标准和生命末期时间段的异质性导致结果差异巨大,且治疗意图往往不明确。患者、地理和病理因素以及姑息/临终关怀的参与,均被确定为治疗强度差异的影响因素。

结论

相当一部分癌症患者在生命末期接受了侵入性且昂贵的手术。报告存在显著异质性,患者纳入标准和生命末期时间框架存在差异,这表明文献中存在不确定性。目前尚无法确定生命末期手术治疗强度可能不适当的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b96/11661707/33540a67453b/as9-5-e514-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验